Jennifer Beebe-Dimmer
Office Address
87 E. Canfield Avenue
Detroit, MI 48201
313-578-4209
Department
Oncology
Research Interests
- Genetic Epidemiology of Genitourinary Cancers
- Obesity, Metabolic Syndrome and Prostate Cancer
- Racial Disparity in Prostate Cancer Risk and Outcomes
Detroit ROCS study
Research Description
Dr. Beebe-Dimmer is the Leader of the Population Studies and Disparities Research Program and the Scientific Director of the Epidemiology Research Core at the Karmanos Cancer Institute (KCI) and a co-investigator on the Metropolitan Detroit Cancer Surveillance System cancer registry. Her research program focuses on the contribution of germline variants to hereditary prostate cancer and understanding the biologic underpinnings of racial disparity in cancer risk and outcomes, as well as the contribution of obesity, physical inactivity and associated cardiometabolic abnormalities on risk of cancer as well as outcomes after cancer diagnoses. She is the MPI on the Detroit Research On Cancer Survivors (ROCS) Study, which has enrolled more than 5,000 African American cancer survivors and is focused on understanding the causes of poorer outcomes in this population. She is the MPI on a recently funded P01 focused on understanding the genetic landscape of African American cancer survivors diagnosed with multiple primary cancers leveraging the Detroit ROCS resource. She is the PI, MPI and Qualified Collaborator on a number of externally-funded, peer-reviewed investigations focused exclusively on investigating the contribution of genetic and environmental determinants to the observed racial disparity in prostate cancer risk and outcomes after diagnosis in African American men including the RESPOND cohort which is the largest single investigation focused on understanding the genetic underpinnings of prostate cancer in African American men.
Recent Publications
Trendowski MR, Ruterbusch JJ, Baird TE, Wenzlaff AS, Pandolfi SS, Hastert TA, Schwartz AG, Beebe-Dimmer JL. Correlates of health-related quality of life in African Americans diagnosed with cancer: a review of survivorship studies and the Detroit research on cancer survivors cohort. Cancer Metastasis Rev. 2024:10.1007/s10555-024-10200-y.
Trendowski MR, Ruterbusch JJ, Baird T, Kyko JM, Martin JL, Schwartz AG, Markey GE, Badr MS, Beebe-Dimmer JL. Sleep health and quality of life in the Detroit Research on Cancer Survivors cohort. J Cancer Surviv. 2024:10.1007/s11764-024-01568-5.
Hastert TA, McDougall JA, Robinson JRM, Palakshappa D, Seaton R, Ruterbusch JJ, Beebe-Dimmer JL, Schwartz AG. Age at diagnosis and social risks among Black cancer survivors: Results from the Detroit Research on Cancer Survivors cohort. Cancer. 2024;130:2060-73.
Hastert TA, Kyko JM, Ruterbusch JJ, Robinson JRM, Kamen CS, Beebe-Dimmer JL, Nair M, Thompson HS, Schwartz AG. Caregiver costs and financial burden in caregivers of African American cancer survivors. J Cancer Surviv. 2024;18:565-74.
Robinson JRM, Hastert TA, Beebe-Dimmer JL, Schwartz AG, Ruterbusch JJ, Pandolfi SS, Rundle AG. Housing instability and psychological distress in African American cancer survivors: findings from the Detroit Research on Cancer Survivors study. J Cancer Surviv. 2023:10.1007/s11764-023-01471-5.
Shore ND, Polikarpov DM, Pieczonka CM, Henderson RJ, Bailen JL, Saltzstein DR, Concepcion RS, Beebe-Dimmer JL, Ruterbusch JJ, Levin RA, Wissmueller S, Le TH, Gillatt DA, Chan DW, Deng N, Siddireddy JS, Lu Y, Campbell DH, Walsh BJ. Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer. Urol Oncol. 2023;41:454.e9-454.e16.
Raychaudhuri S, Kyko JM, Ruterbusch JJ, Pandolfi SS, Beebe-Dimmer JL, Schwartz AG, Simon MS. The impact of preexisting comorbidities on receipt of cancer therapy among women with Stage I-III breast cancer in the Detroit Research on Cancer Survivors cohort. Cancer Med. 2023;12:19021-32.
Beebe-Dimmer JL, Finlay DG, Ruterbusch JJ, Baird T, Simon MS, Abrams J, Harper FWK, Podgorski I, Heath EI. The impact of high intensity interval training in a diverse group of cancer survivors: CAPABLE, a pilot study. Prev Med Rep. 2023;35:102288.
Wharram CE, Kyko JM, Ruterbusch JJ, Beebe-Dimmer JL, Schwartz AG, Cote ML. Use of electronic cigarettes among African American cancer survivors. Cancer. 2023;129:3334-45.
Banning K, Fucinari J, Fielder A, Ruterbusch JJ, Beebe-Dimmer JL, Schwartz AG, Wallbillich JJ, Cote ML. Quality of life in endometrial cancer survivors by grade of disease. Cancer Med. 2023;12):13675-86.
Trendowski MR, Kyko JM, Lusk CM, Ruterbusch JJ, Hastert TA, Harper FWK, Thompson H, Beebe-Dimmer JL, Schwartz AG. Evaluation of health behaviors and overall quality of life in younger adult African American cancer survivors. Cancer Med. 2023;12:684-95.
Trendowski MR, Sample C, Baird T, Sadeghpour A, Moon D, Ruterbusch JJ, Beebe-Dimmer JL, Cooney KA. Germline Variants in DNA Damage Repair Genes and HOXB13 Among Black Patients With Early-Onset Prostate Cancer. JCO Precis Oncol. 2022;6:e2200460.
Hastert TA, Ruterbusch JJ, Abrams J, Nair M, Wenzlaff AS, Beebe-Dimmer JL, Pandolfi SS, Schwartz AG. Financial Hardship by Age at Diagnosis Including in Young Adulthood among African American Cancer Survivors. Cancer Epidemiol Biomarkers Prev. 2022;31:876-84.
Beebe-Dimmer JL, Lusk CM, Ruterbusch JJ, Baird TE, Pandolfi SS, Wenzlaff AS, Hastert TA, Harper FWK, Thompson HS, Schwartz AG. The impact of the COVID-19 pandemic on African American cancer survivors. Cancer. 2022;128:839-48.
Education/Training
BA (1992): University of Wisconsin
MPH (1997): University of Michigan, Ann Arbor, Michigan
PhD Epidemiological Sciences (2001): University of Michigan, Ann Arbor, Michigan
Post-Doc in Urology (2002-2004): University of Michigan, Ann Arbor, Michigan
Courses Taught
CB7430 Cancer Epidemiology